+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Affinity Ligands Market (2023 Edition) - Analysis By Type (Antibodies, Ig Binding Proteins, Lectins, Enzymes, Others), End Use, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

  • PDF Icon

    Report

  • 219 Pages
  • February 2023
  • Region: Global
  • Azoth Analytics
  • ID: 5744598
The global Affinity Ligands market was valued at USD 170.8 billion in 2021 and is anticipated to expand at a CAGR of 11.15% between 2023 and 2028. The rising demand for affinity ligands in several applications, including protein purification, drug development, and diagnostic testing, is driving up demand for Affinity Ligands.

Antibodies were the first (and continue to be the most popular) affinity ligand technology, and they are used in a variety of applications such as manufacturing solutions, research techniques, diagnostics, and therapeutic approaches. Antibodies account for 60.75% of the overall market share by type segment in 2021.

Demand for innovative affinity ligands such as aptamers is also being driven by the development of affinity ligands with increased binding affinity, simpler manufacturing processes, and cheaper production costs.

The most prominent use of Affinity Ligand is affinity chromatography, which is a separation process based upon a particular interaction between the analyte of interest and a ligand that is covalently attached to a resin. It is a simple, rapid, selective, and efficient protein purification method that can purify tens of thousands of folds in a single step.

The Americas Region acquires a majority share of the affinity ligands market in 2021 due to robust R&D investment and the presence of top life science enterprises in the region.

Scope of the Report

  • The report analyses the Affinity Ligands Market by Value (USD Billion).
  • The report presents the analysis of Affinity Ligands Market for the historical period of 2018-2021, the base year 2022 and the forecast period of 2023-2028.
  • The report analyses the Affinity Ligands Market By End Use (Therapeutics, Diagnostics, Research Tools)
  • The report analyses the Affinity Ligands Market By Type (Antibodies, Ig Binding Proteins, Lectins, Enzymes, Other Types)
  • The Global Affinity Ligands Market has been analysed by countries (United States, Canada, Germany, UK, France, Italy, China, Japan, South Korea, India).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, By type and End Use
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies profiled in the report include, Repligen Corp., Aptamer Group, Abcam Group, Thermo Fisher Scientific, Merck KGaA, Kaneka Corporation, Proteintech, EpigenTek, Santa Cruz Biotechnology Inc., and AMS Biotechnology Europe Ltd.

Key Target Audience:

  • Academic Institutions
  • Leading Affinity Ligands Brands
  • Research & Development Organizations
  • Pharmaceutical Companies
  • Biotechnology Companies

Table of Contents

1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology

2. Strategic Recommendations

3. Global Affinity Ligands Market: Historic and Forecast (2018-2028)
3.1 Impact Analysis of Macro Economic Factors on Affinity Ligands Market
3.2 Global Affinity Ligands Market: Ecosystem Analysis
3.2.1 Affinity Ligands Positioning and Target Molecule
3.2.2 Lectin affinity Ligands: Properties and Sources
3.2.3 Technology matrix of key Affinity Ligand Companies
3.3 Global Affinity Ligands Market: Dashboard
3.4 Global Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
3.5 Impact of COVID-19 on Affinity Ligands Market
3.6 Global Affinity Ligands Market Segmentation : By End Uses
3.6.1 Global Affinity Ligands Market, By End Uses Overview
3.6.2 Global Affinity Ligands Market Size, By Therapeutics, By Value, 2018H-2028F (USD Billion & CAGR)
3.6.3 Global Affinity Ligands Market Size, By Diagnostics, By Value, 2018H-2028F (USD Billion & CAGR)
3.6.4 Global Affinity Ligands Market Size, By Research Tools, By Value, 2018H-2028F (USD Billion & CAGR)
3.7 Global Affinity Ligands Market Segmentation : By Type
3.7.1 Global Affinity Ligands Market, By Type Overview
3.7.2 Global Affinity Ligands Market Size, By Antibodies, By Value, 2018H-2028F (USD Billion & CAGR)
3.7.3 Global Affinity Ligands Market Size, By Ig Binding Proteins, By Value, 2018H-2028F (USD Billion & CAGR)
3.7.4 Global Affinity Ligands Market Size, By Lectins, By Value, 2018H-2028F (USD Billion & CAGR)
3.7.5 Global Affinity Ligands Market Size, By Enzymes, By Value, 2018H-2028F (USD Billion & CAGR)
3.7.6 Global Affinity Ligands Market Size, By Other Types, By Value, 2018H-2028F (USD Billion & CAGR)

4. Global Affinity Ligands Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot

5. Americas Affinity Ligands Market: Historic and Forecast (2018-2028)
5.1 Americas Affinity Ligands Market: Snapshot
5.2 Americas Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.3 Americas Affinity Ligands Market: Key Factors
5.4 Americas Affinity Ligands Market Segmentation : By End Uses
5.4.1 Americas Affinity Ligands Market, By End Uses Overview
5.4.2 Americas Affinity Ligands Market Size, By Therapeutics, By Value, 2018H-2028F (USD Billion & CAGR)
5.4.3 Americas Affinity Ligands Market Size, By Diagnostics, By Value, 2018H-2028F (USD Billion & CAGR)
5.4.4 Americas Affinity Ligands Market Size, By Research Tools, By Value, 2018H-2028F (USD Billion & CAGR)
5.5 Americas Affinity Ligands Market Segmentation : By Type
5.5.1 Americas Affinity Ligands Market, By Type Overview
5.5.2 Americas Affinity Ligands Market Size, By Antibodies, By Value, 2018H-2028F (USD Billion & CAGR)
5.5.3 Americas Affinity Ligands Market Size, By Ig Binding Proteins, By Value, 2018H-2028F (USD Billion & CAGR)
5.5.4 Americas Affinity Ligands Market Size, By Lectins, By Value, 2018H-2028F (USD Billion & CAGR)
5.5.5 Americas Affinity Ligands Market Size, By Enzymes, By Value, 2018H-2028F (USD Billion & CAGR)
5.5.6 Americas Affinity Ligands Market Size, By Other Types, By Value, 2018H-2028F (USD Billion & CAGR)
5.6 Americas Affinity Ligands Market Segmentation : By Country
5.6.1 Americas Affinity Ligands Market Segmentation, By Country Overview
5.6.2 United States Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.6.2.1 United States Affinity Ligands Market, By End Uses
5.6.2.2 United States Affinity Ligands Market, By Type
5.6.3 Canada Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.6.3.1 Canada Affinity Ligands Market, By End Uses
5.6.3.2 Canada Affinity Ligands Market, By Type
5.6.4 Rest of Americas Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
5.6.4.1 Rest of Americas Affinity Ligands Market, By End Uses
5.6.4.2 Rest of Americas Affinity Ligands Market, By Type

6. Europe Affinity Ligands Market: Historic and Forecast (2018-2028)
6.1 Europe Affinity Ligands Market: Snapshot
6.2 Europe Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.3 Europe Affinity Ligands Market: Key Factors
6.4 Europe Affinity Ligands Market Segmentation : By End Uses
6.4.1 Europe Affinity Ligands Market, By End Uses Overview
6.4.2 Europe Affinity Ligands Market Size, By Therapeutics, By Value, 2018H-2028F (USD Billion & CAGR)
6.4.3 Europe Affinity Ligands Market Size, By Diagnostics, By Value, 2018H-2028F (USD Billion & CAGR)
6.4.4 Europe Affinity Ligands Market Size, By Research Tools, By Value, 2018H-2028F (USD Billion & CAGR)
6.5 Europe Affinity Ligands Market Segmentation : By Type
6.5.1 Europe Affinity Ligands Market, By Type Overview
6.5.2 Europe Affinity Ligands Market Size, By Antibodies, By Value, 2018H-2028F (USD Billion & CAGR)
6.5.3 Europe Affinity Ligands Market Size, By Ig Binding Proteins, By Value, 2018H-2028F (USD Billion & CAGR)
6.5.4 Europe Affinity Ligands Market Size, By Lectins, By Value, 2018H-2028F (USD Billion & CAGR)
6.5.5 Europe Affinity Ligands Market Size, By Enzymes, By Value, 2018H-2028F (USD Billion & CAGR)
6.5.6 Europe Affinity Ligands Market Size, By Other Types, By Value, 2018H-2028F (USD Billion & CAGR)
6.6 Europe Affinity Ligands Market Segmentation : By Country
6.6.1 Europe Affinity Ligands Market Segmentation, By Country, Overview
6.6.2 Germany Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.6.2.1 Germany Affinity Ligands Market, By End Uses
6.6.2.2 Germany Affinity Ligands Market, By Type
6.6.3 United Kingdom Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.6.3.1 United Kingdom Affinity Ligands Market, By End Uses
6.6.3.2 United Kingdom Affinity Ligands Market, By Type
6.6.4 France Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.6.4.1 France Affinity Ligands Market, By End Uses
6.6.4.2 France Affinity Ligands Market, By Type
6.6.5 Italy Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.6.5.1 Italy Affinity Ligands Market, By End Uses
6.6.5.2 Italy Affinity Ligands Market, By Type
6.6.6 Rest of Europe Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
6.6.6.1 Rest of Europe Affinity Ligands Market, By End Uses
6.6.6.2 Rest of Europe Affinity Ligands Market, By Type

7 Asia Pacific Affinity Ligands Market: Historic and Forecast (2018-2028)
7.1 Asia Pacific Affinity Ligands Market: Snapshot
7.2 Asia Pacific Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.3 Asia Pacific Affinity Ligands Market: Key Factors
7.4 Asia Pacific Affinity Ligands Market Segmentation : By End Uses
7.4.1 Asia Pacific Affinity Ligands Market, By End Uses Overview
7.4.2 Asia Pacific Affinity Ligands Market Size, By Therapeutics, By Value, 2018H-2028F (USD Billion & CAGR)
7.4.3 Asia Pacific Affinity Ligands Market Size, By Diagnostics, By Value, 2018H-2028F (USD Billion & CAGR)
7.4.4 Asia Pacific Affinity Ligands Market Size, By Research Tools, By Value, 2018H-2028F (USD Billion & CAGR)
7.5 Asia Pacific Affinity Ligands Market Segmentation : By Type
7.5.1 Asia-pacific affinity ligands market, by Type overview
7.5.2 Asia Pacific Affinity Ligands Market Size, By Antibodies, By Value, 2018H-2028F (USD Billion & CAGR)
7.5.3 Asia Pacific Affinity Ligands Market Size, By Ig Binding Proteins, By Value, 2018H-2028F (USD Billion & CAGR)
7.5.4 Asia Pacific Affinity Ligands Market Size, By Lectins, By Value, 2018H-2028F (USD Billion & CAGR)
7.5.5 Asia Pacific Affinity Ligands Market Size, By Enzymes, By Value, 2018H-2028F (USD Billion & CAGR)
7.5.6 Asia Pacific Affinity Ligands Market Size, By Other Types, By Value, 2018H-2028F (USD Billion & CAGR)
7.6 Asia Pacific Affinity Ligands Market Segmentation: By Country
7.6.1 Asia Pacific Affinity Ligands Market, By Country Overview
7.6.2 China Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.6.2.1 China Affinity Ligands Market, By End Uses
7.6.2.2 China Affinity Ligands Market, By Type
7.6.3 Japan Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.6.3.1 Japan Affinity Ligands Market, By End Uses
7.6.3.2 Japan Affinity Ligands Market, By Type
7.6.4 South Korea Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.6.4.1 South Korea Affinity Ligands Market, By End Uses
7.6.4.2 South Korea Affinity Ligands Market, By Type
7.6.5 India Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.6.5.1 India Affinity Ligands Market, By End Uses
7.6.5.2 India Affinity Ligands Market, By Type
7.6.6 Rest Of Asia Pacific Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
7.6.6.1 Rest Of Asia Pacific Affinity Ligands Market, By End Uses
7.6.6.2 Rest Of Asia Pacific Affinity Ligands Market, By Type

8. Middle East & Africa Affinity Ligands Market: Historic and Forecast (2018-2028)
8.1 Middle East & Africa Affinity Ligands Market: Snapshot
8.2 Middle East & Africa Affinity Ligands Market: Market Size and CAGR, 2018-2028 (USD Billion & CAGR)
8.3 Middle East & Africa Affinity Ligands Market: Key Factors
8.4 Middle East & Africa Affinity Ligands Market Segmentation : By End Uses
8.4.1 Middle East & Africa Affinity Ligands Market, By End Uses Overview
8.4.2 Middle East & Africa Affinity Ligands Market Size, By Therapeutics, By Value, 2018H-2028F (USD Billion & CAGR)
8.4.3 Middle East & Africa Affinity Ligands Market Size, By Diagnostics, By Value, 2018H-2028F (USD Billion & CAGR)
8.4.4 Middle East & Africa Affinity Ligands Market Size, By Research Tools, By Value, 2018H-2028F (USD Billion & CAGR)
8.5 Middle East & Africa Affinity Ligands Market Segmentation : By Type
8.5.1 Middle East & Africa Affinity Ligands Market, By Type Overview
8.5.2 Middle East & Africa Affinity Ligands Market Size, By Antibodies, By Value, 2018H-2028F (USD Billion & CAGR)
8.5.3 Middle East & Africa Affinity Ligands Market Size, By Ig Binding Proteins, By Value, 2018H-2028F (USD Billion & CAGR)
8.5.4 Middle East & Africa Affinity Ligands Market Size, By Lectins, By Value, 2018H-2028F (USD Billion & CAGR)
8.5.5 Middle East & Africa Affinity Ligands Market Size, By Enzymes, By Value, 2018H-2028F (USD Billion & CAGR)
8.5.6 Middle East & Africa Affinity Ligands Market Size, By Other Types, By Value, 2018H-2028F (USD Billion & CAGR)

9. Market Dynamics
9.1 Impact assessment of Market Dynamics on Global Affinity Ligands Market
9.2 Drivers
9.3 Restraints
9.4 Trends

10. Industry Ecosystem Analysis
10.1 Macro-Economic Factor Assessment
10.2 Value Chain Analysis
10.3 Porter’s Five Forces Model

11. Competitive Positioning
11.1 Companies’ Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Affinity Ligands Market
11.4 Company Profiles
11.4.1 Repligen Corp
11.4.2 Aptamer Group
11.4.3 Abcam Group
11.4.4 Thermo Fisher Scientific
11.4.5 Merck KGaA
11.4.6 Kaneka Corporation
11.4.7 Proteintech
11.4.8 EpigenTek
11.4.9 Santa Cruz Biotechnology Inc.
11.4.10 AMS Biotechnology Europe Ltd

Table Information